CN107235843B - 一种2-苯基-1,2-二氢萘-1-醇外消旋化合物及其衍生物的合成方法 - Google Patents

一种2-苯基-1,2-二氢萘-1-醇外消旋化合物及其衍生物的合成方法 Download PDF

Info

Publication number
CN107235843B
CN107235843B CN201710391062.3A CN201710391062A CN107235843B CN 107235843 B CN107235843 B CN 107235843B CN 201710391062 A CN201710391062 A CN 201710391062A CN 107235843 B CN107235843 B CN 107235843B
Authority
CN
China
Prior art keywords
phenyl
dihydronaphthalene
racemic compound
compound
nmr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201710391062.3A
Other languages
English (en)
Other versions
CN107235843A (zh
Inventor
杨定乔
仵瑞华
陈文坤
杨文�
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
South China Normal University
Original Assignee
South China Normal University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by South China Normal University filed Critical South China Normal University
Priority to CN201710391062.3A priority Critical patent/CN107235843B/zh
Publication of CN107235843A publication Critical patent/CN107235843A/zh
Application granted granted Critical
Publication of CN107235843B publication Critical patent/CN107235843B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/12Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/13Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
    • C07C205/18Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/09Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis
    • C07C29/10Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis of ethers, including cyclic ethers, e.g. oxiranes
    • C07C29/103Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by hydrolysis of ethers, including cyclic ethers, e.g. oxiranes of cyclic ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/23Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
    • C07C35/31Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system containing eight carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/46O-metal derivatives of the cyclically bound hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/48Halogenated derivatives
    • C07C35/52Alcohols with a condensed ring system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/01Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis
    • C07C37/055Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis the substituted group being bound to oxygen, e.g. ether group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/24Halogenated derivatives
    • C07C39/38Halogenated derivatives with at least one hydroxy group on a condensed ring system containing two rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/22Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of halogens; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/26Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/225Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00Ethers; Compounds having groups, groups or groups
    • C07C43/02Ethers
    • C07C43/20Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
    • C07C43/23Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明涉及二氢化萘结构单元中间体的合成技术领域,具体为一种2‑苯基‑1,2‑二氢萘‑1‑醇外消旋化合物及其衍生物的合成方法,以及通过该方法合成的新的2‑苯基‑1,2‑二氢萘‑1‑醇外消旋化合物或其衍生物。本发明通过Pt(COD)Cl2与有机配体形成的过渡金属配合物作为催化剂,催化氧杂苯并降冰片烯与芳基亚磺酸钠反应,可高效合成2‑苯基‑1,2‑二氢萘‑1‑醇外消旋化合物及其衍生物,且反应条件温和,在50‑80℃下即可完成反应。当以适量的PPh3作为有机配体与Pt(COD)Cl2形成过渡金属配合物催化剂且同时使用添加剂AgSbF6,并以CH3OH为溶剂时,反应时间短,且合成2‑苯基‑1,2‑二氢萘‑1‑醇外消旋化合物的产率可高达92%。

Description

一种2-苯基-1,2-二氢萘-1-醇外消旋化合物及其衍生物的合 成方法
技术领域
本发明涉及二氢化萘结构单元中间体的合成技术领域,尤其涉及一种2-苯基-1,2-二氢萘-1-醇外消旋化合物及其衍生物的合成方法,以及通过该方法合成新的2-苯基-1,2-二氢萘-1-醇外消旋化合物或其衍生物。
背景技术
四氢化萘结构单元是许多具有生物活性的天然产物及药物分子中常见的骨架之一,在许多肾上腺激素、抗生素以及中国紫杉醇中的异紫杉脂素、去氧鬼臼素葡萄糖酯苷等化合物中都含有四氢化萘基本结构。这类化合物具有许多特殊的生理活性和药理活性,如抗抑郁、消炎止痛、抗帕金森、抗癌等。相应的合成研究也因此受到化学家们的广泛关注,过渡金属催化氧(氮)杂二环烯烃的不对称开环反应是一种合成此类手性药物中间体的一种方法,它可以通过一步开环反应构建两个手性碳中心。在手性过渡金属配合物的催化下,氧(氮)杂二环烯烃与亲核试剂发生开环反应,可以得到一种高对映立体选择性、具有两个手性中心的二氢化萘骨架单元的开环产物。该产物具有四种立体化学结构构型,分别为1,2-(R,R)、1,2-(S,S)、1,2-(R,S)和1,2-(S,R)。由于此类开环反应具有催化剂用量少、产率高和对映选择性高等特点,化学家们对此产生了浓厚的兴趣,并取得了很好的研究结果。过渡金属Ni、Cu、Ru、Rh、Ir、Pt和Pd催化氧(氮)杂二环烯烃的开环反应,具有较好的区域选择性、对映选择性和手性诱导立体控制,其中,常用的亲核试剂主要包括有机锌试剂、有机铝试剂、有机锂试剂、有机硼酸试剂、格利雅试剂、炔烃试剂等。但是,尽管目前已合成出多种有效的过渡金属配合物催化剂应用于氧(氮)杂二环烯烃开环反应的研究,但没有任何一种催化剂能适用于所有底物与不同的亲核试剂的开环反应。因此,研究高立体化学选择性、高对映选择性、高催化活性的过渡金属配合物催化剂,实现高效立体选择性的开环反应,探索出更适合的反应条件,仍然是将来需要研究的重点课题。
发明内容
本发明针对现有技术使用氧杂苯并降冰片烯与芳基亚磺酸钠合成外消旋化合物时存在产率低的问题,提供一种使用氧杂苯并降冰片烯与芳基亚磺酸钠可高效合成2-苯基-1,2-二氢萘-1-醇外消旋化合物及其衍生物的方法。
本发明的另一个目的是提供通过上述方法合成新的2-苯基-1,2-二氢萘-1-醇外消旋化合物或其衍生物。
为实现上述目的,本发明采用以下技术方案。
一种2-苯基-1,2-二氢萘-1-醇外消旋化合物及其衍生物的合成方法,包括以下步骤:
S1、在氮气或惰性气体的气氛保护下,将Pt(COD)Cl2和有机配体置于有机溶剂中络合5-40min,形成催化体系;所述Pt(COD)Cl2与有机配体的物质的量之比为1:1-4。
优选的,在步骤S1中,还包括向有机溶剂中加入含银盐添加剂,所述的Pt(COD)Cl2、有机配体和含银盐添加剂在有机溶剂中反应5-40min,形成催化体系。
具体的,所述含银盐添加剂为AgSbF6或AgBF4
具体的,所述有机配体为PPh3、DPPF、P(C6H5CH3)3、P(C6H3F2)3、(S)-binap、(S)-Tol-binap、(S)-segphos或(S)-DTBM-segphos。
具体的,所述有机溶剂为CH3OH、i-PrOH、CH3CH2OH或1,4-dioxane。
S2、向催化体系中加入反应物氧杂苯并降冰片烯和芳基亚磺酸钠,得反应体系,使反应体系在50-80℃下反应;所述氧杂苯并降冰片烯与芳基亚磺酸钠的物质的量之比为1:1-3,所述氧杂苯并降冰片烯与Pt(COD)Cl2的物质的量之比为100:2.5-10。
所述氧杂苯并降冰片烯的结构如下:
其中,R1为H或卤素,R2为H或烷氧基。
具体的,所述卤素为Br;所述烷氧基为OCH3
所述芳基亚磺酸钠盐为C6H5SO2Na、4-FC6H4SO2Na、4-ClC6H4SO2Na、4-BrC6H4SO2Na、3-ClC6H4SO2Na、2-ClC6H4SO2Na、4-H3CC6H4SO2Na、4-O2NC6H4SO2Na、4-F3CC6H4SO2Na、2,5-(CH3)2C6H4SO2Na、2,4,6-(CH3)3C6H4SO2Na、1-萘亚磺酸钠或2-萘亚磺酸钠。
S3、反应至反应体系中的反应物消失或浓度不再变化时,将反应体系冷却至室温,然后分离提纯产物,收集2-苯基-1,2-二氢萘-1-醇外消旋化合物或其衍生物。
具体的,步骤S3中,反应体系冷却至室温后,先真空浓缩除去溶剂,残留物再通过柱层析色谱法纯化,收集2-苯基-1,2-二氢萘-1-醇外消旋化合物或其衍生物。
通过以上方法合成了新的2-苯基-1,2-二氢萘-1-醇外消旋化合物或其衍生物,所述化合物的结构如下:
与现有技术相比,本发明的有益效果是:本发明以Pt(COD)Cl2与有机配体形成的过渡金属配合物作为催化剂,催化氧杂苯并降冰片烯与芳基亚磺酸钠反应,可高效合成2-苯基-1,2-二氢萘-1-醇外消旋化合物或其衍生物,且反应条件温和,在50-80℃下即可完成反应。当以适量的PPh3作为有机配体与Pt(COD)Cl2形成过渡金属配合物催化剂且同时使用添加剂AgSbF6,并以CH3OH为溶剂时,反应时间短,且合成2-苯基-1,2-二氢萘-1-醇外消旋化合物的产率可高达92%。
附图说明
图1为化合物3ce的核磁共振氢谱;
图2为化合物3ce的核磁共振碳谱;
图3为化合物3cf的核磁共振氢谱;
图4为化合物3cf的核磁共振碳谱;
图5为化合物4dc的核磁共振氢谱;
图6为化合物4dc的核磁共振碳谱。
具体实施方式
为了更充分的理解本发明的技术内容,下面结合具体实施例对本发明的技术方案作进一步介绍和说明。
实施例1-57
实施例1-57提供的2-苯基-1,2-二氢萘-1-醇外消旋化合物或其衍生物的合成方法,具体步骤如下:
(1)在室温及氮气或惰性气体的气氛保护下,先将铂催化剂和有机配体置于有机溶剂中,若使用添加剂,则向有机溶剂中加入所用添加剂,混合物在室温下络合5-40min,形成催化体系。
(2)向催化体系中加入反应物氧杂苯并降冰片烯和芳基亚磺酸钠,得反应体系,使反应体系在一定温度下反应。
(3)反应至反应体系中的氧杂苯并降冰片烯消失或浓度不再变化时,将反应体系冷却至室温,然后先真空浓缩除去溶剂,再通过柱层析色谱法纯化,收集2-苯基-1,2-二氢萘-1-醇外消旋化合物或其衍生物。
实施例1-57的反应条件及产量和产率如下表1和表2所示。
表1实施例1-57的反应条件
表1中反应物1指氧杂苯并降冰片烯,反应物2指芳基亚磺酸钠;反应物1和反应物2所包含的具体化合物的结构式如下表3所示。
表2实施例1-57的反应条件及产量和产率
表2中各实施例合成的2-苯基-1,2-二氢萘-1-醇外消旋化合物或其衍生物的结构式如下表4所示。
表3反应物1和反应物2所包含的具体化合物的结构式
表4实施例29-57合成的2-苯基-1,2-二氢萘-1-醇外消旋化合物或其衍生物的结构式
由上述实施例合成的化合物3ce、3cf和4dc的核磁共振氢谱和核磁共振碳谱如图1-6所示。
由实施例1-57合成的上述化合物的性状、产量、产率、熔点、硅胶柱层析的比移值Rf、核磁共振氢谱、核磁共振碳谱和质谱数据分别如下所示。
化合物3aa:(1S*,2R*)-2-Phenyl-1,2-dihydronaphthalen-1-ol
无色油状(35.9mg,81%).Rf=0.25(ethylacetate/petroleum ether 1:20,v/v).1H NMR(500MHz,CDCl3):δ7.28–7.19(m,6H),7.19–7.15(m,2H),7.11–7.07(m,1H),6.63(dd,J=9.6,2.0Hz,1H),6.05(dd,J=9.6,4.0Hz,1H),4.85(t,J=6.7Hz,1H),3.79(ddd,J=6.0,4.0,2.1Hz,1H),1.43(d,J=7.9Hz,1H).13C{1H}NMR(125MHz,CDCl3)δ137.8,136.1,132.7,129.7,129.3,128.7,128.4,128.3,128.1,127.5,126.8,126.4,71.4,47.4.MS(EI)m/z:[M-3H]calcd for C16H11O,219.08;found 219.04.
化合物3ab:(1S*,2R*)-2-(4-Fluorophenyl)-1,2-dihydronaphthalen-1-ol
白色固体(34.6mg,72%yield).mp 85–86℃.Rf=0.13(ethylacetate/petroleumether 1:20,v/v).1H NMR(600MHz,CDCl3)δ7.29–7.15(m,6H),6.94(t,J=8.6Hz,2H),6.65(dd,J=9.6,1.8Hz,1H),6.04(dd,J=9.6,4.1Hz,1H),4.87(d,J=6.0Hz,1H),3.80–3.78(m,1H),1.18(d,J=6.4Hz,1H).13C{1H}NMR(150MHz,CDCl3)δ163.3(d,1JC-F=243.8Hz),161.7,136.3,133.6(d,4JC-F=3Hz),132.8,131.1,129.9,128.7,128.6,128.5,126.7(d,3JC-F=15Hz),115.8,115.6(d,2JC-F=21.0Hz),71.6,46.8.19F NMR(376MHz,CDCl3)δ-115.4.MS(EI)m/z:[M-3H]calcd for C16H10FO,237.07;found 237.23.
化合物3ac:(1S*,2R*)-2-(4-Chlorophenyl)-1,2-dihydronaphthalen-1-ol
白色固体(44.2mg,87%yield).mp 113–114℃.Rf=0.13(ethylacetate/petroleum ether 1:20,v/v).1H NMR(600MHz,CDCl3)δ7.26–7.16(m,5H),7.13–7.08(m,3H),6.63(d,J=9.6Hz,1H),6.00(dd,J=9.6,4.0Hz,1H),4.83(d,J=4.0Hz,1H),3.75(s,1H),1.41(s,1H).13C{1H}NMR(150MHz,CDCl3)δ136.3,136.0,133.2,132.5,130.7,129.3,128.7,128.5,128.5,128.2,126.6,126.5,71.3,46.7.MS(EI)m/z:[M+Na]+calcd forC16H13ClONa,279.07;found 279.13.
化合物3ad:(1S*,2R*)-2-(4-Bromophenyl)-1,2-dihydronaphthalen-1-ol
无色油状(37.1mg,62%yield).Rf=0.13on silica gel(ethylacetate/petroleum ether 1:20,v/v).1H NMR(400MHz,CDCl3)δ7.46–7.39(m,2H),7.35–7.25(m,3H),7.19–7.15(m,1H),7.13(d,J=8.3Hz,2H),6.71(dd,J=9.6,1.9Hz,1H),6.07(dd,J=9.6,4.1Hz,1H),4.91(d,J=5.9Hz,1H),3.84–3.79(m,1H),1.52(s,1H).13C{1H}NMR(100MHz,CDCl3)δ136.8,135.9,132.4,131.6,131.0,129.1,128.5,128.4,128.2,126.5,126.5,121.3,71.2,46.8.MS(EI)m/z:[M–3H]-calcd for C16H10BrO,297.00;found 297.46.
化合物3ae:(1S*,2R*)-2-(3-Chlorophenyl)-1,2-dihydronaphthalen-1-ol
无色油状(46.1mg,90%yield).Rf=0.21(ethylacetate/petroleum ether 1:20,v/v).1H NMR(500MHz,CDCl3)δ7.29–7.15(m,6H),6.94(t,J=8.6Hz,2H),6.65(dd,J=9.6,1.8Hz,1H),6.04(dd,J=9.6,4.1Hz,1H),4.87(d,J=6.0Hz,1H),3.80–3.78(m,1H),1.18(t,J=6.4Hz,1H).13C{1H}NMR(150MHz,CDCl3)13C NMR(125MHz,CDCl3)δ139.9,135.4,133.9,131.9,129.3,129.0,128.4,128.1,128.1,127.8,127.1,127.0,126.3,126.1,70.8,46.7.MS(EI)m/z:[M–3H]-calcd for C16H10ClO,253.04;found 253.70.
化合物3af:(1S*,2R*)-2-(2-Chlorophenyl)-1,2-dihydronaphthalen-1-ol
无色油状(42.5mg,83%yield).Rf=0.19(ethylacetate/petroleum ether 1:20,v/v).1H NMR(500MHz,CDCl3)δ7.36(dd,J=7.4,1.9Hz,1H),7.34–7.25(m,3H),7.25–7.14(m,4H),7.13(d,J=7.4Hz,1H),6.67(dd,J=9.6,2.7Hz,1H),5.97(dd,J=9.6,2.5Hz,1H),4.82(d,J=5.0Hz,1H),4.42(dt,J=5.3,2.8Hz,1H),1.48(s,1H).13C{1H}NMR(125MHz,CDCl3)δ137.5,135.8,134.8,132.8,131.6,130.2,129.7,129.5,129.1,129.0,128.7,128.6,127.6,127.4,69.9,44.7.MS(EI)m/z:[M-3H]calcd for C16H10ClO,253.04;found253.13.
化合物3ag:(1S*,2R*)-2-(4-Methylphenyl)-1,2-dihydronaphthalen-1-ol
无色油状(39.1mg,83%yield).Rf=0.20(ethylacetate/petroleum ether 1:20,v/v).1H NMR(600MHz,CDCl3)δ7.25(d,J=7.3Hz,1H),7.20(t,J=7.3Hz,1H),7.16–7.13(m,1H),7.08–7.01(m,5H),6.60(d,J=9.6Hz,1H),6.02(dd,J=9.6,4.1Hz,1H),4.83(d,J=5.6Hz,1H),3.74(s,1H),2.23(s,3H),1.40(s,1H).13C{1H}NMR(150MHz,CDCl3)δ136.7,135.8,134.0,132.3,129.5,129.0,128.8,127.9,127.7,127.60,126.3,126.0,71.0,46.5,20.7.MS(EI)m/z:[M-3H]calcd for C17H13O,233.10;found 233.16.
化合物3ah:(1S*,2R*)-2-(4-Nitrophenyl)-1,2-dihydronaphthalen-1-ol
浅黄色固体(21.3mg,40%yield).mp 122.3–123.6℃.Rf=0.3(ethylacetate/petroleum ether 1:5,v/v).1H NMR(600MHz,CDCl3)δ8.12(d,J=8.7Hz,2H),7.41(d,J=8.7Hz,2H),7.28(dt,J=24.6,6.2Hz,3H),7.17(d,J=6.9Hz,1H),6.73(dd,J=9.6,2.0Hz,1H),6.04(dd,J=9.6,3.8Hz,1H),4.90(d,J=5.2Hz,1H),3.92(dd,J=6.8,4.7Hz,1H),1.54(s,1H).13C{1H}NMR(150MHz,CDCl3)δ147.3,146.5,135.6,132.1,130.2,129.0,128.8,128.5,128.1,126.8,126.7,123.6,71.2,58.5,47.3.MS(EI)m/z:[M–3H]calcd forC16H10NO3,264.08;found 264.05.
化合物3ai:(1S*,2R*)-2-(4-Trifluoromethylphenyl)-1,2-dihydronaphthalen-1-ol
白色固体(38.9mg,67%yield).mp 112–114℃.Rf=0.11(ethylacetate/petroleum ether 1:20,v/v).1H NMR(400MHz,CDCl3)δ7.49(d,J=8.0Hz,2H),7.31(d,J=8.0Hz,2H),7.27–7.17(m,3H),7.12(d,J=7.2Hz,1H),6.67(dd,J=9.6,1.5Hz,1H),6.02(dd,J=9.6,3.8Hz,1H),4.85(d,J=5.7Hz,1H),3.84(s,1H),1.46(s,1H).13C{1H}NMR(100MHz,CDCl3)δ143.1,136.4,133.0,130.3,130.2,129.5(q,2JC-F=30.0Hz),129.4,129.3,129.0,127.4,127.3(q,1JC-F=271.3Hz),126.1,126.0(q,3JC-F=3.7Hz),72.0,47.9.19F NMR(376MHz,CDCl3)δ-62.51.MS(EI)m/z:[M–3H]calcd for C17H10F3O,287.06;found 287.08.
化合物3aj:(1S*,2R*)-2-(2,5-Dimethylphenyl)-1,2-dihydronaphthalen-1-ol
无色油状(39.0mg,78%yield).Rf=0.27(ethyl acetate/petroleum ether1:20,v/v).1H NMR(400MHz,CDCl3)δ7.24(dd,J=9.8,7.3Hz,2H),7.17(d,J=7.2Hz,1H),7.10(d,J=7.3Hz,1H),7.03(d,J=6.9Hz,2H),6.92(d,J=7.3Hz,1H),6.63(dd,J=9.6,2.5Hz,1H),5.98(dd,J=9.6,2.7Hz,1H),4.66(d,J=5.0Hz,1H),4.07(dt,J=5.3,2.8Hz,1H),2.28(s,3H),2.19(s,3H),1.48(s,1H).13C{1H}NMR(100MHz,CDCl3)δ136.1,135.2,134.7,132.8,131.9,130.0,129.9,129.4,128.1,127.4,127.3,127.2,127.1,126.0,68.8,42.8,20.3,18.7.MS(EI)m/z:[M-3H]calcd for C18H15O,247.11;found 247.21.
化合物3al:(1S*,2R*)-1',2'-Dihydro-[1,2']binaphthalenyl-1'-ol
无色油状(29.9mg,55%yield).Rf=0.22(ethylacetate/petroleum ether1:20,v/v).1H NMR(600MHz,CDCl3)δ8.05(d,J=8.4Hz,1H),7.82–7.79(m,1H),7.70(t,J=7.8Hz,1H),7.47–7.35(m,4H),7.25(ddd,J=7.2,6.4,2.4Hz,2H),7.19–7.16(m,1H),7.14–7.12(m,1H),6.70(dt,J=7.8,3.9Hz,1H),6.10(dd,J=9.6,2.5Hz,1H),4.82(d,J=4.9Hz,1H),4.70(s,1H),1.42(s,1H).13C{1H}NMR(150MHz,CDCl3)δ135.5,135.1,134.4,132.9,132.2,130.6,129.5,129.1,128.6,128.4,128.3,128.2,127.3,127.1,126.7,126.0,125.9,123.4,70.6,43.1.MS(EI)m/z:[M+CH3]+calcd for C21H19O,287.15;found 287.06.
化合物3am:(1S*,2R*)-1,2-Dihydro-[2,2'-binaphthalen]-1-ol
无色油状(26.1mg,48%yield).Rf=0.22(ethylacetate/petroleum ether 1:20,v/v).1H NMR(600MHz,CDCl3)δ7.82–7.76(m,4H),7.48–7.43(m,2H),7.36–7.30(m,3H),7.24(ddd,J=22.5,14.4,6.8Hz,2H),6.77(dd,J=9.6,2.0Hz,1H),6.22(dd,J=9.6,4.0Hz,1H),5.01(d,J=5.9Hz,1H),4.04(ddd,J=6.0,4.0,2.1Hz,1H),1.53(s,1H).13C{1H}NMR(150MHz,CDCl3)δ136.1,135.3,133.4,132.8,132.7,129.5,128.4,128.4,128.3,128.1,127.8,127.6,127.3,126.7,126.5,126.1,125.8,71.3,47.5.MS(EI)m/z:[M–3H]calcd for C20H13O,269.10;found 268.88.
化合物4ba:1,4-Dimethoxy-6-phenylnaphthalene
白色固体(50.2mg,95%yield).mp 87.2–87.8℃.Rf=0.2(ethylacetate/petroleum ether 1:10,v/v).1H NMR(600MHz,CDCl3)δ8.40(d,J=1.8Hz,1H),8.23(d,J=8.7Hz,1H),7.72(ddd,J=8.3,7.5,1.4Hz,3H),7.45–7.42(m,2H),7.34–7.31(m,1H),6.69–6.65(m,2H),3.94(d,J=1.8Hz,6H).13C{1H}NMR(150MHz,CDCl3)δ150.3,150.1,141.9,139.1,129.3,128.1,127.8,127.2,126.0,125.9,123.0,120.4,104.2,103.9,56.4,56.3.MS(EI)m/z:[M–CH3]calcd for C17H13O2,249.08;found 248.52.
化合物4bg:1,4-Dimethoxy-6-(p-tolyl)naphthalene
白色固体(56.8mg,90%yield).mp 113.2–114.4℃.Rf=0.23(ethylacetate/petroleum ether 1:10,v/v).1H NMR(400MHz,CDCl3)δ8.44(d,J=1.6Hz,1H),8.27(d,J=8.7Hz,1H),7.78(dd,J=8.7,1.9Hz,1H),7.68(d,J=8.1Hz,2H),7.30(d,J=7.9Hz,2H),6.71(q,J=8.3Hz,2H),3.98(t,J=3.4Hz,6H),2.43(s,3H).13C{1H}NMR(100MHz,CDCl3)δ150.1,149.9,138.8,138.7,137.4,129.9,127.7,127.0,125.6,122.8,119.8,104.0,103.5,56.13,21.5.HRMS(ESI-ion trap)m/z:[M+H]+calcd for C19H19O2,279.1386;found279.1375.
化合物3bc:
(1S*,2R*)-2-(4-Chlorophenyl)-5,8-dimethoxy-1,2-dihydronaphthalen-1-ol
白色固体(50.8mg,80%yield).mp 115.6–117.2℃.Rf=0.3(ethylacetate/petroleum ether 1:5,v/v).1H NMR(600MHz,CDCl3)δ7.28(d,J=9.2Hz,4H),7.01(dd,J=9.8,3.2Hz,1H),6.74(q,J=9.0Hz,2H),6.00–5.97(m,1H),4.98(d,J=4.2Hz,1H),3.75(d,J=8.3Hz,6H),3.69–3.66(m,1H),1.15(p,J=9.0Hz,1H).13C{1H}NMR(150MHz,CDCl3)δ149.6,148.7,138.1,131.7,129.5,127.5,127.4,123.2,121.3,121.2,110.5,110.0,63.3,55.2,55.1,45.6.MS(EI)m/z:[M-3H]-calcd for C18H14ClO3,313.06;found 313.14.
化合物3bd:
(1S*,2R*)-2-(4-Bromophenyl)-5,8-dimethoxy-1,2-dihydronaphthalen-1-ol
白色固体(28.8mg,40%yield).mp 91.6–93.8℃.Rf=0.29(ethylacetate/petroleum ether 1:5,v/v).1H NMR(600MHz,CDCl3)δ7.45–7.41(m,2H),7.24–7.21(m,2H),7.03–6.99(m,1H),6.77–6.72(m,2H),5.98(ddd,J=9.8,2.2,1.6Hz,1H),4.99(d,J=4.1Hz,1H),3.75(d,J=8.1Hz,6H),3.67–3.65(m,1H),1.53(s,1H).13C{1H}NMR(150MHz,CDCl3)δ150.6,149.7,139.6,131.5,130.9,128.3,124.2,122.3,122.2,120.8,111.5,111.0,64.2,56.2,56.1,46.7.MS(EI)m/z:[M-H]calcd for C18H16BrO3,359.02;found359.01.
化合物3be:
(1S*,2R*)-2-(3-Chlorophenyl)-5,8-dimethoxy-1,2-dihydronaphthalen-1-ol
无色油状(57.9mg,92%yield).Rf=0.24(ethylacetate/petroleum ether 1:5,v/v).1H NMR(600MHz,CDCl3)δ7.36(s,1H),7.24(d,J=5.2Hz,2H),7.22–7.19(m,1H),7.02(dd,J=9.8,3.2Hz,1H),6.75(q,J=8.9Hz,2H),6.02–5.99(m,1H),5.02–5.00(m,1H),3.75(d,J=5.9Hz,6H),3.69–3.67(m,1H),1.53(s,1H).13C{1H}NMR(150MHz,CDCl3)δ150.9,150.0,143.0,134.6,130.0,129.6,128.3,127.6,127.4,124.6,122.7,122.5,111.8,111.4,64.5,56.5,56.4,47.3.MS(EI)m/z:[M+Na]+calcd for C18H17ClO3Na,339.08;found338.84.
化合物3bf:
(1S*,2R*)-2-(2-Chlorophenyl)-5,8-dimethoxy-1,2-dihydronaphthalen-1-ol
白色固体(55.4mg,92%yield).mp 98–99℃.Rf=0.3(ethylacetate/petroleumether 1:5,v/v).1H NMR(600MHz,CDCl3)δ7.50(dd,J=7.6,1.5Hz,1H),7.42(dd,J=7.9,1.0Hz,1H),7.30(td,J=7.5,1.0Hz,1H),7.25–7.22(m,1H),7.11(dd,J=9.8,3.2Hz,1H),6.82(q,J=9.0Hz,2H),6.07–6.04(m,1H),5.23(d,J=4.2Hz,1H),4.35–4.33(m,1H),3.83(d,J=4.8Hz,6H),1.59(d,J=33.7Hz,1H).13C{1H}NMR(150MHz,CDCl3)δ150.8,149.6,137.9,134.0,131.4,129.4,128.6,128.2,126.8,124.1,122.2,122.1,111.5,111.0,61.6,56.2,56.1,43.8.MS(EI)m/z:[M–3H]calcd for C18H14ClO3,313.06;found 313.14.
化合物3ca:(1S*,2R*)-6,7-Dibromo-2-phenyl-1,2-dihydronaphthalen-1-ol
无色油状(68.2mg,90%yield).Rf=0.29(ethylacetate/petroleum ether 1:10,v/v).1H NMR(600MHz,CDCl3)δ7.51(s,1H),7.33(d,J=3.8Hz,1H),7.23(tt,J=4.7,3.6Hz,3H),7.12–7.09(m,2H),6.53(dd,J=9.6,1.5Hz,1H),6.14(dd,J=9.6,4.8Hz,1H),4.90(t,J=7.0Hz,1H),3.76(ddd,J=6.5,4.8,1.6Hz,1H),1.44(d,J=8.6Hz,1H).13C{1H}NMR(150MHz,CDCl3)δ137.1,135.6,133.5,131.8,131.4,130.8,129.3,128.9,127.9,126.4,124.0,123.6,70.3,46.7.MS(EI)m/z:[M–H]calcd for C16H11Br2O,376.93;found376.94.
化合物3cg:
(1S*,2R*)-6,7-Dibromo-2-(4-methylphenyl)-1,2-dihydronaphthalen-1-ol
白色固体(62.9mg,80%yield).mp108–109℃.Rf=0.24(ethyl acetate/petroleum ether 1:10,v/v).1H NMR(500MHz,CDCl3)δ7.72(d,J=4.5Hz,1H),7.45–7.39(m,1H),7.16(dd,J=7.7,1.8Hz,4H),6.60–6.51(m,1H),6.09(td,J=9.4,3.3Hz,1H),4.79–4.73(m,1H),3.75–3.68(m,1H),2.37(s,3H),2.06(t,J=9.3Hz,1H).13C{1H}NMR(125MHz,CDCl3)δ137.3,137.1,136.6,133.4,132.4,131.2,130.8,129.7,128.3,125.9,124.0,123.5,73.6,49.5,21.1.MS(EI)m/z:[M-CH3]-calcd for C16H11Br2O,376.91;found376.87.
化合物3cc:
(1S*,2R*)-6,7-Dibromo-2-(4-chlorophenyl)-1,2-dihydronaphthalen-1-ol
无色油状(69.87mg,85%yield).Rf=0.3(ethylacetate/petroleum ether 1:10,v/v).1H NMR(400MHz,CDCl3)δ7.51(d,J=9.5Hz,1H),7.32(d,J=3.4Hz,1H),7.02(t,J=6.0Hz,2H),6.97(d,J=8.1Hz,2H),6.50(dd,J=9.7,1.1Hz,1H),6.11(dd,J=9.7,4.9Hz,1H),4.87(d,J=6.7Hz,1H),3.73–3.69(m,1H),1.54–1.47(m,1H).13C{1H}NMR(100MHz,CDCl3)δ137.7,137.3,133.6,132.2,132.0,131.4,130.7,129.6,129.2,126.2,123.9,123.5,70.2,46.2.MS(EI)m/z:[M–H]calcd for C16H10Br2ClO,410.88;found410.81.
化合物3ce:
(1S*,2R*)-6,7-Dibromo-2-(3-chlorophenyl)-1,2-dihydronaphthalen-1-ol
无色油状(71.9mg,87%yield).Rf=0.32(ethylacetate/petroleum ether 1:10,v/v).1H NMR(400MHz,CDCl3)δ7.52(d,J=4.5Hz,1H),7.35(s,1H),7.21–7.12(m,4H),7.02–6.98(m,1H),6.55(dd,J=9.7,1.5Hz,1H),6.09(dd,J=9.7,4.5Hz,1H),4.86(d,J=6.3Hz,1H),3.99(t,J=6.7Hz,1H),3.73(dd,J=7.8,3.1Hz,1H),1.54(t,J=4.6Hz,1H).13C{1H}NMR(100MHz,CDCl3)δ138.3,136.7,134.6,133.1,131.5,131.0,130.9,130.0,129.5,128.0,127.3,127.0,124.3,123.8,70.1,46.5.HRMS(ESI-ion trap)m/z:[M–3H]calcdfor C16H8Br2ClO,408.8628;found 408.8627.
化合物3cf:
(1S*,2R*)-6,7-Dibromo-2-(2-chlorophenyl)-1,2-dihydronaphthalen-1-ol
无色油状(64.4mg,78%yield).Rf=0.32on silica gel(ethylacetate/petroleum ether 1:10,v/v).1H NMR(400MHz,CDCl3)δ7.55(s,1H),7.37(s,1H),7.21–7.14(m,4H),6.57(dd,J=9.7,2.3Hz,1H),6.06(dd,J=9.7,3.5Hz,1H),4.85(d,J=5.3Hz,1H),4.38(dt,J=5.7,2.9Hz,1H),1.53(dd,J=14.8,6.3Hz,1H).13C{1H}NMR(100MHz,CDCl3)δ135.8,135.3,134.3,132.8,132.6,131.2,131.0,130.7,129.7,128.8,127.2,126.6,124.6,123.5,68.4,43.3.HRMS(ESI-ion trap)m/z:[M-3H]calcd for C16H8Br2ClO,408.8628;found 408.8632.
化合物4da:6,7-Dimethoxy-2-phenyl-naphthalene
白色固体(49.6mg,88%yield).mp 121–122℃.Rf=0.35(ethylacetate/petroleum ether 1:10,v/v).1H NMR(500MHz,CDCl3)δ7.82(d,J=1.5Hz,1H),7.66(d,J=8.4Hz,1H),7.63–7.60(m,2H),7.52(dd,J=8.4,1.8Hz,1H),7.38(dd,J=10.6,4.8Hz,2H),7.29–7.24(m,1H),7.07(d,J=19.6Hz,2H),3.93(d,J=1.2Hz,6H).13C{1H}NMR(125MHz,CDCl3)δ149.9,149.6,141.4,137.0,129.5,128.8,128.4,127.3,127.1,126.8,124.4,123.9,106.6,106.1,55.9.MS(EI)m/z:[M-H]calcd for C18H15O2,263.11;found 263.00.
化合物4dg:6,7-Dimethoxy-2-(4-methylphenyl)-naphthalene
白色固体(47.8mg,86%yield).mp 136.2–137.3℃.Rf=0.36(ethylacetate/petroleum ether 1:10,v/v).1H NMR(600MHz,CDCl3)δ7.80(d,J=1.4Hz,1H),7.65(d,J=8.4Hz,1H),7.51(ddd,J=7.1,4.2,1.8Hz,3H),7.20(d,J=7.9Hz,2H),7.09(s,1H),7.05(s,1H),3.93(d,J=2.2Hz,6H),2.33(s,3H).13C{1H}NMR(150MHz,CDCl3)δ150.4,150.1,139.1,137.5,137.4,130.1,130.1,128.8,127.7,127.3,124.6,124.4,107.1,106.7,56.5,21.7.HRMS(ESI-ion trap)m/z:[M+H]+calcd forC19H19O2 279.1386;found,279.1375.
化合物4dc:6,7-Dimethoxy-2-(4-chlorophenyl)-naphthalene
白色固体(47.1mg,79%yield).mp 139–140℃.Rf=0.15(ethylacetate/petroleum ether 1:10,v/v).1H NMR(600MHz,CDCl3)δ8.34(d,J=1.7Hz,1H),8.17(d,J=8.7Hz,1H),7.68(dd,J=8.7,1.8Hz,1H),7.58(d,J=8.1Hz,2H),7.20(d,J=8.0Hz,2H),6.65–6.60(m,2H),3.90(d,J=2.7Hz,6H).13C{1H}NMR(150MHz,CDCl3)δ150.6,150.4,140.5,136.4,133.8,130.1,129.6,129.2,129.1,127.6,125.0,124.2,107.2,106.7,56.6,56.5.HRMS(ESI-ion trap)m/z:[M+3H]+calcd for C18H18ClO2,301.0998;found 301.1002.
化合物4di:6,7-Dimethoxy-2-(4-trifluoromethylphenyl)-naphthalene
白色固体(36.5mg,55%yield).mp 113–114℃.Rf=0.3(ethyl acetate/petroleum ether 1:10,v/v).1H NMR(400MHz,CDCl3)δ7.82(s,1H),7.72–7.60(m,6H),7.49(dd,J=8.4,1.7Hz,1H),7.08(d,J=15.6Hz,2H),3.93(s,6H).13C{1H}NMR(100MHz,CDCl3)δ149.7(q,2JC-F=30Hz),144.6,135.1,129.3,129.1(q,3JC-F=315Hz),128.6,127.1(q,3JC-F=18Hz),126.8,125.5,125.4(q,4JC-F=4Hz),124.5,123.4,123.2,106.3,105.7,55.6.19FNMR(376MHz,CDCl3)δ-62.30.HRMS(ESI-ion trap)m/z:[M+H]+calcd for C19H16F3O2,333.1103;found 333.1094.
化合物3ea:(1S*,2R*)-2-Phenyl-1,2-dihydrotriphenylen-1-ol
白色固体(26.4mg,41%yield).mp 156–158℃.Rf=0.23(ethylacetate/petroleum ether 1:10,v/v).1H NMR(500MHz,CDCl3):δ8.70–8.64(m,2H),8.27–8.22(m,1H),8.21–8.14(m,1H),7.64–7.50(m,5H),7.48–7.45(m,2H),7.42–7.37(m,2H),7.34–7.28(m,1H),6.41(ddd,J=9.8,2.3,1.5Hz,1H),5.36(t,J=4.7Hz,1H),3.98–3.89(m,1H),1.60(d,J=5.7Hz,1H).13C{1H}NMR(125MHz,CDCl3):δ140.3,131.1,131.0,130.8,130.1,129.4,129.0,128.9,128.8,127.6,127.5,127.2,127.1,126.8,126.6,124.3,124.2,124.0,123.3,123.2,67.8,48.2.MS(EI)m/z:[M–3H]calcd for C24H15O,319.11;found 319.86.
以上所述仅以实施例来进一步说明本发明的技术内容,以便于读者更容易理解,但不代表本发明的实施方式仅限于此,任何依本发明所做的技术延伸或再创造,均受本发明的保护。

Claims (4)

1.一种2-苯基-1,2-二氢萘-1-醇外消旋化合物及其衍生物的合成方法,其特征在于,
所述2-苯基-1,2-二氢萘-1-醇外消旋化合物及其衍生物的结构式是:
所述合成方法包括以下步骤:
S1、在氮气或惰性气体的气氛保护下,将Pt(COD)Cl2和有机配体置于有机溶剂中络合5-40min,形成催化体系;所述Pt(COD)Cl2与有机配体的物质的量之比为1:1-4;所述有机配体为P(C6H5CH3)3、P(C6H3F2)3或(S)-binap;
S2、向催化体系中加入反应物氧杂苯并降冰片烯和芳基亚磺酸钠,得反应体系,使反应体系在50-80℃下反应;所述氧杂苯并降冰片烯与芳基亚磺酸钠的物质的量之比为1:1-3,所述氧杂苯并降冰片烯与Pt(COD)Cl2的物质的量之比为100:2.5-10;
所述氧杂苯并降冰片烯的结构如下:
其中,R1为H或卤素,R2为H或烷氧基;所述卤素为Br,所述烷氧基为OCH3
所述芳基亚磺酸钠为C6H5SO2Na、4-FC6H4SO2Na、4-ClC6H4SO2Na、4-BrC6H4SO2Na、3-ClC6H4SO2Na、2-ClC6H4SO2Na、4-H3CC6H4SO2Na、4-O2NC6H4SO2Na、4-F3CC6H4SO2Na、2,5-(CH3)2C6H4SO2Na、1-萘亚磺酸钠或2-萘亚磺酸钠;
S3、反应至反应体系中的反应物消失或浓度不再变化时,将反应体系冷却至室温,然后分离提纯产物,收集2-苯基-1,2-二氢萘-1-醇外消旋化合物或其衍生物。
2.根据权利要求1所述一种2-苯基-1,2-二氢萘-1-醇外消旋化合物及其衍生物的合成方法,其特征在于,步骤S1中,还包括向有机溶剂中加入含银盐添加剂,所述含银盐添加剂为AgSbF6或AgBF4,所述Pt(COD)Cl2、有机配体和含银盐添加剂在有机溶剂中反应5-40min,形成催化体系。
3.根据权利要求1所述一种2-苯基-1,2-二氢萘-1-醇外消旋化合物及其衍生物的合成方法,其特征在于,步骤S1中,所述有机溶剂为CH3OH、i-PrOH、CH3CH2OH或1,4-二氧己环。
4.根据权利要求1-3中任一项所述一种2-苯基-1,2-二氢萘-1-醇外消旋化合物及其衍生物的合成方法,其特征在于,步骤S3中,反应体系冷却至室温后,先真空浓缩,再通过柱色谱法纯化,收集2-苯基-1,2-二氢萘-1-醇外消旋化合物或其衍生物。
CN201710391062.3A 2017-05-27 2017-05-27 一种2-苯基-1,2-二氢萘-1-醇外消旋化合物及其衍生物的合成方法 Expired - Fee Related CN107235843B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710391062.3A CN107235843B (zh) 2017-05-27 2017-05-27 一种2-苯基-1,2-二氢萘-1-醇外消旋化合物及其衍生物的合成方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710391062.3A CN107235843B (zh) 2017-05-27 2017-05-27 一种2-苯基-1,2-二氢萘-1-醇外消旋化合物及其衍生物的合成方法

Publications (2)

Publication Number Publication Date
CN107235843A CN107235843A (zh) 2017-10-10
CN107235843B true CN107235843B (zh) 2019-08-13

Family

ID=59984624

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710391062.3A Expired - Fee Related CN107235843B (zh) 2017-05-27 2017-05-27 一种2-苯基-1,2-二氢萘-1-醇外消旋化合物及其衍生物的合成方法

Country Status (1)

Country Link
CN (1) CN107235843B (zh)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005068482A1 (en) * 2004-01-14 2005-07-28 Phoenix Chemicals Limited Chiral metallocen ligands for use in homogeneous catalysis
CN105541662A (zh) * 2015-12-28 2016-05-04 云南大学 二氢萘类化合物的固相合成方法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005068482A1 (en) * 2004-01-14 2005-07-28 Phoenix Chemicals Limited Chiral metallocen ligands for use in homogeneous catalysis
CN105541662A (zh) * 2015-12-28 2016-05-04 云南大学 二氢萘类化合物的固相合成方法

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Palladium-Catalyzed syn-Stereocontrolled Ring-Opening of Oxabicyclic Alkenes with Sodium Arylsulfinates;Yue Li等;《J. Org. Chem.》;20160506;第81卷;第4744-4750页 *
Triarylphosphines as Aryl Donors for Pd(II)-Catalyzed Aromatic Coupling of Oxabenzonorbornadienes;Hui Zhou等;《Org. Lett.》;20150910;第17卷;第4628-4631页 *
Yue Li等.Palladium-Catalyzed syn-Stereocontrolled Ring-Opening of Oxabicyclic Alkenes with Sodium Arylsulfinates.《J. Org. Chem.》.2016,第81卷第4744-4750页. *
过渡金属催化氧(氮)杂二环烯烃与碳负离子型亲核试剂的不对称开环反应研究进展;仵瑞华等;《有机化学》;20160602;第36卷;第2368-2379页 *

Also Published As

Publication number Publication date
CN107235843A (zh) 2017-10-10

Similar Documents

Publication Publication Date Title
Jiang et al. Recent developments in catalytic asymmetric inverse-electron-demand Diels–Alder reaction
Takahashi et al. A catalytic enantioselective reaction using a C2-symmetric disulfonamide as a chiral ligand: Simmons-Smith cyclopropanation of allylic alcohols by the Et2Zn-CH2I2-disulfonamide system
Hao et al. Metal-free nitro-carbocyclization of 1, 6-enynes with t BuONO and TEMPO
CN107722068A (zh) 三齿氮膦配体与其配合物、及其在酮的不对称催化氢化中的应用
WO2007007646A1 (ja) 均一系不斉水素化反応用触媒
Cao et al. Palladium-catalyzed asymmetric [3+ 2] cycloaddition to construct 1, 3-indandione and oxindole-fused spiropyrazolidine scaffolds
KR20030005180A (ko) 3,6-디알킬-5,6-디하이드로-4-하이드록시-피란-2-온의합성 방법
CN109956970A (zh) 联苯型三齿配体钌络合物及其制备方法和应用
Hatano et al. Highly enantioselective alkaloid synthesis via ene-type cyclizations catalyzed by cationic chiral palladium (II) complexes of PN-ligands with an achiral oxazoline unit
Lu et al. Synthesis of chiral γ-lactones via a RuPHOX-Ru catalyzed asymmetric hydrogenation of aroylacrylic acids
Llamas et al. Copper (I)-catalyzed enantioselective 1, 3-dipolar cycloaddition of azomethine ylides with vinyl sulfones
Zhang et al. Application of asymmetric aminohydroxylation to heteroaromatic acrylates
CN106748766B (zh) 一种氟代手性化合物的绿色合成方法
JP4649645B2 (ja) 光学活性アルコール化合物の製法
CN107235843B (zh) 一种2-苯基-1,2-二氢萘-1-醇外消旋化合物及其衍生物的合成方法
JP2008260734A (ja) 有機ホウ素化合物の製造方法
CN108299486B (zh) 一种基于铁催化制备环丙基硼酸酯化合物的方法
Yadav et al. Efficient synthesis of optically active 2-azido-1-arylethanols via oxazaborolidine-catalysed asymmetric borane reduction
JP2001526111A (ja) モリブデン、タングステンまたはクロムを有するキラル配位子をベースとする触媒組成物およびアリル性基質の不斉アルキル化の方法
Zhou et al. Catalytic asymmetric syntheses of (−)-oudemanisin A and its diastereomer
Yanagisawa et al. Asymmetric Aldol Reaction Catalyzed by a Chiral Phosphine–Silver Complex
Grach et al. Screening of amino sulfur ferrocenes as catalysts for the enantioselective addition of diethylzinc to benzaldehyde
CN106279014A (zh) 一种合成苯甘氨酸类衍生物及方法
CN108129348B (zh) 叠氮三氟甲氧基化合物及其合成方法
Cardinal et al. Preparation of 2, 3, 3-Triarylacrylic Acid Esters Using Suzuki–Miyaura Coupling Reactions

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20190813

Termination date: 20210527

CF01 Termination of patent right due to non-payment of annual fee